Our founders started the company with the goal of creating a more provider-friendly testing service that prides itself on delivering prompt, accurate, reliable and easy to understand results. Employing state of the art technology and testing for a wide array of analytes, our team of PhDs and clinical technologists is able to keep ahead of the needs of our community. The Rxight pharmacogenetic test was developed and is performed by MD Labs.
Our methodologies deliver quick, accurate, and cost-effective drug testing, while enhancing patients’ prescription adherence, improved treatment outcomes, and overall patient care. We exclusively use UPLC-MS/MS for quantitative testing to provide some of the lowest validated cutoff levels in the industry for better detection of specific drugs and metabolites. Our in-house team of PhDs and clinical technologists are constantly developing and implementing assays based on client requests and pharmacotherapeutic trends.
Rxight is integrated with PioneerRx pharmacy systems. Rxight™ places the pharmacist at the center of pharmacogenetics; patients purchase and order the test from the pharmacist and results go directly to the pharmacist, not to the patient. Patients must have a Personalized Medication Review (PMR)® with a pharmacist trained in PGx and certified to perform a PMR®, before they get access to their results. And the pharmacist engages the prescribing physician with guidance concerning any Gene-Drug Interactions that may impact medication therapy following the same protocol used for Drug-Drug Interactions.